Kim Min-Hee, Son Jaewoong, Nam Hae Jeong, Ko Seong-Gyu, Choi Inhwa
Department of Clinical Korean Medicine, Graduate School, Kyung Hee University, Seoul, Republic of Korea; Department of Otorhinolaryngology of Korean Medicine, Kyung Hee University Hospital at Gangdong, Seoul, Republic of Korea.
Department of Ophthalmology & Otorhinolaryngology, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea.
Evid Based Complement Alternat Med. 2016;2016:9202675. doi: 10.1155/2016/9202675. Epub 2016 Sep 6.
Hyeonggaeyeongyo-tang (HYT) is an ancient formula of oriental medicine traditionally used to treat rhinitis; however, clinical evidence has not yet been established. The aim of this study was to investigate the short-term and long-term efficacy and safety of HYT for chronic rhinitis. Adult subjects with chronic rhinitis symptoms were recruited. The subjects received HYT for 4 weeks and had follow-up period of 8 weeks. Any medicines used to treat nasal symptoms were not permitted during the study. The skin prick test was performed to distinguish the subjects with allergic rhinitis from those with nonallergic rhinitis. After treatment, the total nasal symptoms score and the Rhinoconjunctivitis Quality of Life Questionnaire score significantly improved in the whole subject group, in the allergic rhinitis group, and in the nonallergic rhinitis group, with no adverse events. This improvement lasted during a follow-up period of 8 weeks. Total IgE and eosinophil levels showed no significant difference after treatment in the allergic rhinitis group. HYT improved nasal symptoms and quality of life in patients with allergic rhinitis and nonallergic rhinitis. This is the first clinical study to evaluate the use of HYT to treat patients with rhinitis. This trial has been registered with the ClinicalTrials.gov Identifier NCT02477293.
杏佳延宇汤(HYT)是一种传统用于治疗鼻炎的古老东方医学方剂;然而,尚未有临床证据。本研究的目的是调查杏佳延宇汤治疗慢性鼻炎的短期和长期疗效及安全性。招募了有慢性鼻炎症状的成年受试者。受试者接受杏佳延宇汤治疗4周,并进行8周的随访期。研究期间不允许使用任何治疗鼻部症状的药物。进行皮肤点刺试验以区分过敏性鼻炎患者和非过敏性鼻炎患者。治疗后,整个受试者组、过敏性鼻炎组和非过敏性鼻炎组的总鼻部症状评分和鼻结膜炎生活质量问卷评分均显著改善,且无不良事件。这种改善在8周的随访期内持续存在。过敏性鼻炎组治疗后总IgE和嗜酸性粒细胞水平无显著差异。杏佳延宇汤改善了过敏性鼻炎和非过敏性鼻炎患者的鼻部症状和生活质量。这是第一项评估杏佳延宇汤治疗鼻炎患者疗效的临床研究。该试验已在ClinicalTrials.gov注册,标识符为NCT02477293。